Article | 3/1/2013

Breaking a Vicious Cycle: Commentary on Tumor-Marker Diagnostics

Science Translational Medicine
Gary Gustavsen, Manager
This article explores the root causes of the vicious cycle leading to the pronounced undervaluation of tumor-biomarker tests, and the resulting failure to become standard clinical practice. A roadmap to break the cycle is described, recommending changes in processes across the board to stakeholders nationwide.
Read here.